Search

Your search keyword '"Silicic Acid adverse effects"' showing total 125 results

Search Constraints

Start Over You searched for: Descriptor "Silicic Acid adverse effects" Remove constraint Descriptor: "Silicic Acid adverse effects"
125 results on '"Silicic Acid adverse effects"'

Search Results

1. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.

2. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.

3. Opinion of the Scientific Committee on Consumer Safety (SCCS) - Revision of the opinion on the safety of the use of Silica, Hydrated Silica, and Silica Surface Modified with Alkyl Silylates (nano form) in cosmetic products.

4. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.

5. Synthesis and characterization of diopside particles and their suitability along with chitosan matrix for bone tissue engineering in vitro and in vivo.

6. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].

7. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.

8. The influence of desensitizing dentifrices on pain induced by in-office bleaching.

9. Gaviscon: not always entirely safe!

10. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

11. [Gastroesophageal reflux disease during pregnancy].

12. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.

13. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].

14. Water fluoridation: pollutant or panacea?

15. Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study.

16. [Clinical application of AW glass ceramic prosthesis in spinal surgery].

17. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].

18. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients.

19. Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers.

20. Colloidal silicic acid for oral and topical treatment of aged skin, fragile hair and brittle nails in females.

21. A study of Spanish sepiolite workers.

22. [The hygienic characteristics of the state of the air in cement manufacture].

23. Silica stone--development due to long time oral trisilicate intake.

24. The effects of etching, micro-abrasion, and bleaching on surface enamel.

25. Induction of micronuclei in peripheral blood lymphocytes of patients treated for rheumatoid or osteo-arthritis of the knee with dysprosium-165 hydroxide macroaggregates or yttrium-90 silicate.

26. Respiratory health risks among nonmetal miners.

27. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].

28. [Cancer risk caused by synthetic mineral fibers].

29. Metsovo-tremolite asbestos fibres: in vitro effects on mutation, chromosome aberration, cell transformation and intercellular communication.

30. Health effects of synthetic vitreous fibers.

31. Giant negative U waves in a patient with uncontrolled hypertension and severe hypokalemia.

32. [Pulmonary fibrosis after inhalation of amorphous silicic acid].

33. Risk assessment using exposure intensity: an application to vermiculite mining.

34. [Silica calculi: a case report].

36. Metsovo lung outside Metsovo. Endemic pleural calcifications in the ophiolite belts of Greece.

38. Assessments of lung digestion methods for recovery of fibers.

39. [Silicate urolithiasis: a case report].

40. Temperature rise due to finishing of direct restorative materials.

41. Irritative symptoms and exposure to mineral wool.

43. Beware of antacids!

44. Mineral fibres, fibrosis, and asbestos bodies in lung tissue from deceased asbestos cement workers.

45. [Gaviscon in reflux symptoms. Results of a drug monitoring study].

46. Cross-infection hazards associated with the use of pumice in dental laboratories.

47. On talc, tremolite, and tergiversation.

48. [Suspended dust from artificial mineral fibers at the work site].

49. [Artificial mineral fibers and the risk of cancer].

50. [The morphologic reaction pattern to fiber dust].

Catalog

Books, media, physical & digital resources